A. Bittermann et al. / Journal of Organometallic Chemistry 693 (2008) 2079–2090
2087
131.73, 129.61, 129.47, 128.99 (Cbenzyl), 119.36 (CCl), 52.83
(CH2). IR (KBr): mmax/cmꢀ1 = 3098, 3012, 2861 (C–Cl),
1586, 1550, 1498, 1456, 1405, 1363, 1343, 1304, 1205,
1181, 1146, 1078, 1032, 769, 731, 709, 697, 607. Anal. Calc.
for C17H15Cl2N2Br (398.12): C, 51.3; H, 3.8; N, 7.0; Cl,
17.8. Found: C, 51.24; H, 3.72; N, 7.05; Cl, 18.21%. MS
(FAB): m/z 319.1 (67%, M+ꢀBr), 317.1 (100%,
M+ꢀBrꢀ2H).
C–H) = 14.8 Hz, CH2benzyl), 5.76 (d, 2H, 2J(H–C–
H) = 14.8 Hz, CH2benzyl), 5.07 (m, 2H, codvinyl), 3.32 (m,
2H, codvinyl), 2.31 (m, 4H, codallyl), 1.88 (m, 4H, codallyl).
13C NMR (CDCl3): d = 183.60 (d, 1J(C–Rh) = 51.5 Hz,
NCN), 136.54, 128.96, 128.26, 128.18, (Cbenzyl), 120.98
(Cimidazol), 98.90, 98.83, 68.49, 68.35 (codvinyl), 54.69
(CH2benzyl), 32.94, 28.85 (codallyl). IR (KBr): mmax
/
cmꢀ1 = 2933, 2905, 2873, 2832, 1637, 1619, 1496, 1453,
1416, 1398, 1361, 1223, 1078, 1029, 960, 766, 727, 715,
699. MS (FAB): m/z 494.1 (4%, M+), 459.1 (21%,
M+ꢀCl), 386.0 (38%, M+ꢀCOD), 351.1 (100%,
M+ꢀClꢀCOD).
4.4. 4,5-Dicyano-1,3-dibenzyl-2-(pentafluorophenyl)-2,3-
dihydro-imidazole 4
In a 5 ml vial equipped with a magnetic stirrer bar pen-
tafluorobenzaldehyde (1.36 g, 6.94 mmol) was dissolved in
1 ml of acetic acid. N,N0-Dibenzyldiaminomaleonitrile
(1.00 g, 3.47 mmol) was added in one portion and the reac-
tion mixture was stirred at room temperature for 2 days.
The brown precipitate was filtered off and washed once
with 5 ml of water and three times with 3 ml of cold meth-
anol. Compound 4 was obtained as a light yellow solid
after drying under reduced pressure (1.317 g, 81%).
4.5.2. Chloro(g4-1,5-COD)(4,5-dichloro-1,3-
dibenzylimidazol-2-yliden)rhodium(I) 6
Two hundred milligrams (0.502 mmol) of 3a, 58 mg
(0.251 mmol) of silver(I) oxide and 124 mg (0.251 mmol)
of [Rh(COD)Cl]2 yielded 6 as of a yellow solid (142 mg,
100%).
1
Mp: 214 °C (decomp.). H NMR (CDCl3): d = 7.37 (m,
10H, CHbenzyl), 6.04 (d, 2H, 2J(H–C–H) = 15.6 Hz,
Mp: 155 °C (decomp.). 1H NMR (CDCl3): d = 7.22 (br,
6H, Cbenzyl), 7.04 (br, 4H, Cbenzyl), 5.79 (s, 1H, NCHN),
4.09 (d, 2H, 2J(H–C–H) = 14.8 Hz, CH2benzyl), 3.94 (d,
2H, 2J(H–C–H) = 14.4 Hz, CH2benzyl). 13C NMR (CDCl3):
d = 146.50, 143.98, 140.49, 138.49, 136.00 (m, CF), 133.22,
128.85, 128.76 (Cbenzyl), 113.88 (CCN), 112.40 (m, CCF),
110.61 (NCCN), 77.66 (NCHN), 54.19 (CH2). IR (KBr):
CH2benzyl), 5.89 (d, 2H, J(H–C–H) = 15.6 Hz, CH2benzyl),
2
5.06 (m, 2H, codvinyl), 3.07 (m, 2H, codvinyl), 2.24 (m, 2H,
codallyl), 2.01 (m, 2H, codallyl), 1.82 (m, 2H, codallyl), 1.68
(m, 2H, codallyl). 13C NMR (CDCl3): d = 186.20 (d,
1J(C–Rh) = 53.0 Hz, NCN), 135.82, 128.90, 128.01,
127.07 (Cbenzyl), 117.20 (CCl), 99.71, 99.64, 69.81, 69.67
(codvinyl), 54.00 (CH2benzyl), 32.66, 28.67 (codallyl). IR
m
max/cmꢀ1 = 2215 (CN), 1655, 1592, 1522, 1511, 1456,
(KBr):
m
max/cmꢀ1 = 2934, 2914, 2878 (C–Cl), 2830
1383, 1359, 1209, 1188, 1150, 1002, 921, 747, 703, 693.
Anal. Calc. for C25H15F5N4 (466.41): C, 64.4; H, 3.24; N,
12.0. Found: C, 64.5; H, 3.10; N, 11.6%. MS (FAB): m/z
467.1 (52%, M+H+), 466.1 (100%, M+).
(C–Cl), 1637, 1618, 1592, 1495, 1454, 1429, 1389, 1350,
1329, 1216, 968, 722, 692. Anal. Calc. for C25H26Cl3N2Rh
(563.75): C, 53.3; H, 4.6; N, 4.97. Found: C, 53.96; H, 4.83;
N, 4.81%. MS (FAB): m/z 562.0 (8%, M+), 527.1 (44%,
M+ꢀCl), 419.0 (100%, M+ꢀClꢀCOD).
4.6. Chloro(g4-1,5-COD)(4,5-dicyano-1,3-
dibenzylimidazol-2-yliden)rhodium(I) 7
4.5. General procedure for the preparation of NHC
complexes 5 and 6
To the solution of imidazolium salt (2 equiv.) in CH2Cl2
(20 ml) silver(I) oxide (1 equiv.) was added in one portion.
Resulting suspension was stirred for 3 h in the darkness,
during which time the black colour gradually diminished.
The reaction mixture was filtered through a small pad of
Celite and 1 equiv. of [Rh(COD)Cl]2 was added in one por-
tion. Almost immediately a white precipitate of silver salt
was formed. The reaction mixture was stirred for addi-
tional 18 h. The solvent was evaporated and the residue
was purified by flash chromatography on silica gel with
CH2Cl2 as eluent.
Ninety-seven milligrams (0.208 mmol) of 4 were dis-
solved in 6 ml of dry mesitylene. 51 mg (0.104 mmol) of
[Rh(COD)Cl]2 were added in one portion and the mixture
was heated to 165 °C. After 16 h the solvent was evapo-
rated and the residue was purified by flash chromatography
on silica gel with CH2Cl2 as eluent. Recrystallisation out of
1-propanole yielded 7 (54 mg, 95%) as a yellow solid.
1
Mp: 132 °C (decomp.). H NMR (CDCl3): d = 7.47 (m,
10H, CHbenzyl), 6.26 (d, 2H, 2J(H–C–H) = 15.2 Hz,
2
2
CH2benzyl), 5.89 (d, H, J(H–C–H) = 15.2 Hz, CH2benzyl),
5.24 (m, 2H, codvinyl), 3.16 (m, 2H, codvinyl), 2.35 (m, 2H,
codallyl), 2.22 (m, 2H, codallyl), 1.92 (m, 4H, codallyl). 13C
NMR (CDCl3): d = 197.33 (d, 1J(C–Rh) = 50.9 Hz,
NCN), 133.54, 129.38, 128.44 (Cbenzyl), 115.76 (CN),
106.43 (CCN), 102.32, 102.25, 70.66, 70.52 (codvinyl),
4.5.1. Chloro(g4-1,5-COD)(1,3-dibenzylimidazol-2-
yliden)rhodium(I) 5
Two hundred milligrams (0.607 mmol) of 2a, 70 mg
(0.304 mmol) of silver(I) oxide and 150 mg (0.304 mmol)
of [Rh(COD)Cl]2 yielded 5 as a yellow solid (150 mg,
100%).
55.88 (CH2benzyl), 32.73, 28.68 (codallyl). IR (KBr): mmax
/
cmꢀ1 = 2938, 2914, 2882, 2830, 2360, 2342, 2238 (CN),
1637, 1617,1497, 1459, 1440, 1400, 1332, 1214, 735, 697.
Anal. Calc. for C27H26ClN4Rh (544.85): C, 59.5; H, 4.81;
1
Mp: 208 °C (decomp.). H NMR (CDCl3): d = 7.38 (m,
10H, CHbenzyl), 6.65 (s, 2H, CHimidazol), 5.88 (d, 2H, 2J(H–